• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Genesis Research and Development Corp Ltd

GEN:NZ

Ticker Delisted

Snapshot for Genesis Research and Development Corp Ltd (GEN)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for GEN

No chart data available.
  • GEN:NZ
  • 1M
  • 1Y
0.000
Interactive GEN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GEN

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. NZSE -
Earnings Per Share (ttm) -0.0044
Est. EPS -
Est. PEG Ratio -
Market Cap (M NZD) 0.00
Shares Outstanding (M) 54.60
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GEN

No data available

Company Profile & Key Executives for GEN

Genesis Research and Development Corporation Limited is a biotechnology company that researches and identifies new molecules that regulate the distribution of information during cell to cell communication which is found in all life systems. Genesis has partnerships with biopharmaceutical, agricultural, and forestry companies to develop and market gene products.

Stephen George HallChief Executive Officer
More Company Profile & Key Executives for GEN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil